07/01 - 09/01
Parc 55 Hotel 55 Cyril Magnin Street, San Francisco, CA 94102
Stand Alliance Davidson Room Level 4 Contact us for a meeting
We will be present at this event together with our partners of the PROVEO Alliance to discuss actual and new development and manufacturing opportunities
Cerbios-Pharma SA is expanding its high-potency API (HPAPI) production and conjugation capabilities. Gabriel Haering, Chief Executive Officer, Cerbios-Pharma SA, outlined the expansion at the DCAT Week ’19 Member Company Announcement Forum, which was held March 18, 2019 in New York.
Cerbios has been awarded second place at the bi-annual Swiss Venture Club Prix.
“This is an important recognition for Cerbios, the founders that created it in the late 70’s, the management and all employees that made this possible” confirms Gabriel Haering, Cerbios’ CEO.
“Being one of the six finalists chosen among 50 companies representing different industrial branches in Ticino was already a great achievement. Reaching the second place among the six finalist is splendid!”
The main criteria for the choice of finalists and winners were the following:
This award is not only a recognition for Cerbios’ strategy and approach but also a commitment towards the future in order to maintain the high standard achieved.